-
-
Fremanezumab: Chronic and episodic migraine medication approved for use within NHS Scotland
-
Posted in Industry News
-
13th Jan 2020
-
Industry news from Teva Pharmaceuticals
Posted in Industry News
13th Jan 2020
Industry news from Teva Pharmaceuticals
Posted in Industry News
06th Jan 2020
News from ATAI and Neuronasal
Posted in Industry News
20th Dec 2019
Industry news from Janssen
Posted in Industry News
18th Dec 2019
Neuroimaging shows AMBAR clinical trial’s positive effects in patients with mild-to-moderate Alzheimer’s disease
Posted in Industry News
10th Dec 2019
Those of us in the room have the power we need to fundamentally improve the quality of multiple sclerosis (MS) care in the UK, reduce variation and offer consistent care at the level we want everywhere, in the next 3 years. In July, 85% of 120 healthcare professionals agreed with this statement (‘Raising the Bar’, […]
Posted in Industry News
05th Dec 2019
Industry news: patients with highly active MS will now have access to cladribine tablets without the additional requirement of a gadolinium-enhanced MRI, following review from NICE.
Posted in Industry News
25th Nov 2019
News about the BNA’s campaign, ‘Credibility in Neuroscience’, an important programme to drive open, transparent and reproducible research.
Posted in Industry News
25th Oct 2019
News from PTC Therapeutics, Inc.
Posted in Industry News
22nd Oct 2019
News from Merck